Andries Napo Leemisa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Andries Napo Leemisa has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Anika Spreen
Institute for Biology, Experimental Biophysics, Humboldt-Universität zu Berlin, 10115 Berlin, Germany
1 shared publication - Bela Erlinghagen
Medical Faculty, Institute for Experimental Epileptology and Cognition Research, University of Bonn, Venusberg Campus 1, 53127 Bonn, Germany
1 shared publication - Dietmar Schmitz
Neuroscience Research Center, Charite-Universitaetsmedizin Berlin, Germany
1 shared publication - Enrico Kuehn
Department Genes–Circuits–Behavior, Max Planck Institute for Biological Intelligence, Am Klopferspitz 18, 82152 Martinsried, Germany
1 shared publication - Enrico Schiewer
Institute for Biology, Experimental Biophysics, Humboldt-Universität zu Berlin, 10115 Berlin, Germany
1 shared publication - Franziska Schneider-Warme
Institute for Experimental Cardiovascular Medicine, University Heart Center Freiburg – Bad Krozingen, Medical Faculty and Medical Center – University of Freiburg, Freiburg im Breisgau, Germany
1 shared publication
Latest Publications
- Open Access
- 28 November 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (48) , eadx1195
Optogenetic silencing by combining a rhodopsin cyclase with an engineered cGMP-gated potassium channel
Since the advent of optogenetics, great progress has been made in developing tools to modulate and detect cellular activity using light. We present a two-component optogenetic silencing tool, RoCK (rhodopsin cyclase/K + channel), which pairs the rhodopsin-guanylyl cyclase CaRhGC with customized SthK K + channels that are engineered to open selectively upon guanosine 3′,5′-monophosphate (cGMP) binding. By enhancing the cGMP sensitivity and open probability of SthK mutants, we obtained four channel variants suited for different levels of cGMP concentration. CaRhGC’s membrane-bound nature enables localized cGMP production, and the lack of dark activity reduces the risk for off-target effects. Optimized RoCK effectively modulated cellular activity in mouse hippocampal neurons, in acute hippocampal slices, and in rabbit cardiomyocytes. In zebrafish, RoCK silenced motor neurons in vivo, suppressing the characteristic coiling behavior of embryos, thus highlighting its potential for behavioral studies. In summary, RoCK expands our optogenetic toolkit threefold for fast cGMP production, fast cGMP sensing, and K + -based cell silencing.
- 28 November 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (48) , eadx1195
Open AccessOptogenetic silencing by combining a rhodopsin cyclase with an engineered cGMP-gated potassium channel
Since the advent of optogenetics, great progress has been made in developing tools to modulate and detect cellular activity using light. We present a two-component optogenetic silencing tool, RoCK (rhodopsin cyclase/K + channel), which pairs the rhodopsin-guanylyl cyclase CaRhGC with customized SthK K + channels that are engineered to open selectively upon guanosine 3′,5′-monophosphate (cGMP) binding. By enhancing the cGMP sensitivity and open probability of SthK mutants, we obtained four channel variants suited for different levels of cGMP concentration. CaRhGC’s membrane-bound nature enables localized cGMP production, and the lack of dark activity reduces the risk for off-target effects. Optimized RoCK effectively modulated cellular activity in mouse hippocampal neurons, in acute hippocampal slices, and in rabbit cardiomyocytes. In zebrafish, RoCK silenced motor neurons in vivo, suppressing the characteristic coiling behavior of embryos, thus highlighting its potential for behavioral studies. In summary, RoCK expands our optogenetic toolkit threefold for fast cGMP production, fast cGMP sensing, and K + -based cell silencing.